Funded Insurance Startups
Five recently dated entries cluster tightly from 2025-09-29 (Rehuman, Seed, undisclosed) to 2025-11-03 (Avallon Labs, Seed, $5M), with three rounds landing…
Five recently dated entries cluster tightly from 2025-09-29 (Rehuman, Seed, undisclosed) to 2025-11-03 (Avallon Labs, Seed, $5M), with three rounds landing in October 2025: Irys Insurtech on 2025-10-16 ($13M), Liberate Innovations on 2025-10-13 ($50M), and Silas Insurtech on 2025-10-03 (Pre-Seed, undisclosed). Disclosed amounts show a clear size outlier: Liberate Innovations’ $50M (2025-10-13) is the only round above $13M and sits far above the next disclosed figure, Irys Insurtech’s $13M (2025-10-16), with Avallon Labs at $5M (2025-11-03).
Geographically, the list is distributed rather than hub-dense, spanning New York (Avallon Labs), Tampa (Irys Insurtech), Palo Alto (Liberate Innovations), and London (Rehuman), with one entry lacking a listed location (Silas Insurtech). Stage signals are mixed: Seed appears twice with one disclosed ($5M) and one undisclosed (Rehuman), while the only Series B shown is Liberate Innovations at $50M (2025-10-13). Undisclosed amounts occur in two of the five rows (Silas Insurtech on 2025-10-03 and Rehuman on 2025-09-29), constraining comparisons beyond the remaining three disclosed rounds.
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in this insurance + AI + B2B software set, and how different is it from the rest?
Liberate Innovations’ $50M disclosed round on 2025-10-13 is the lone disclosed amount far above the others: the next-largest disclosed round is Irys Insurtech at $13M on 2025-10-16, while Avallon Labs is at $5M on 2025-11-03.
Are most of these deals concentrated in a narrow time window?
Yes. All five entries fall between 2025-09-29 (Rehuman) and 2025-11-03 (Avallon Labs), and three separate rounds close in October 2025: Liberate Innovations (2025-10-13), Irys Insurtech (2025-10-16), and Silas Insurtech (2025-10-03).
Which stages dominate, and how does stage relate to disclosed amounts here?
Seed is the most frequent stage with two entries: Avallon Labs (Seed, $5M on 2025-11-03) and Rehuman (Seed, undisclosed on 2025-09-29). The only Series B shown is Liberate Innovations at $50M (2025-10-13), while Silas Insurtech is Pre-Seed (undisclosed) on 2025-10-03.
Are there location patterns, or is the geography spread out?
The geography is spread across different metros rather than concentrated: New York (Avallon Labs, 2025-11-03), Tampa (Irys Insurtech, 2025-10-16), Palo Alto (Liberate Innovations, 2025-10-13), and London (Rehuman, 2025-09-29), with Silas Insurtech listing no location.
Do undisclosed amounts create blind spots for comparing deal size?
They do: 2 of 5 rows show undisclosed amounts (Silas Insurtech on 2025-10-03 and Rehuman on 2025-09-29). With only three disclosed rounds ($5M, $13M, $50M), the $50M Liberate Innovations round becomes the dominant comparison point by default.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.